Drug
Azd0284
Azd0284: highest development phase Phase 1, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| AZD0284 oral solution 2.5 mg/mL NCT03310320 | Phase 1 | Plaque Psoriasis Vulgaris |
Latest
No recent events.
Follow Azd0284 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.